Saturday 17 October 2026 Export XERS’s income statement to Excel — free account

Xeris Biopharma Holdings, Inc.

XERS Healthcare Drug Manufacturers Specialty & Generic

Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024. In the quarter to June 2026, revenue grew 28.7%, EPS fell 1,700.0%, free cash flow grew 8,403.1% and total debt rose 15.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

10.31 0.24 +2.38%

Follow XERS

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: 54.5×
Dividend yield: —
F-score: 8/9
Altman Z: 0.98
Beneish M: −2.58
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	2,065.79	78.59	0.00
P/S ratio Full definition →		5.01	4.32	3.14	4.08
P/FCF ratio Full definition →		133.55	45.09	20.81	24.59
P/Operating CF Full definition →		72.27	62.83	100.21	165.65
P/B ratio Full definition →		0.00	92.00	76.02	0.00
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		5.53	4.73	3.53	4.47
EV/EBITDA Full definition →		57.14	33.70	21.32	28.35
EV/Operating CF Full definition →		139.41	48.23	22.88	26.49
EV/FCF Full definition →		147.56	49.43	23.37	26.94
Quick Ratio Full definition →		1.25	1.48	1.42	0.95
Current Ratio Full definition →		1.93	2.19	2.12	1.45
Net Debt/EBITDA Full definition →		11.88	5.25	9.11	14.08
Debt/Assets Full definition →		59.29%	57.45%	56.43%	61.32%
Debt/Equity Full definition →		(254.90)	16.10	17.00	(25.95)
Asset Turnover Full definition →		0.77	0.83	0.89	0.90
Operating CF/Net income Full definition →		29.68	1.81	4.42	(0.27)
Capex/Depreciation Full definition →		(0.02)	(0.08)	(0.08)	(0.05)
Interest Coverage Full definition →		0.93	2.34	1.15	0.74
Research and Development Expense of Revenue Full definition →		10.06%	9.18%	10.57%	11.58%
Selling, General and Administrative Expense of Revenue Full definition →		62.46%	55.36%	63.93%	66.27%
Intangible Assets out of Total Assets Full definition →		0.31	0.29	0.28	0.26
Share Based Compensation of Revenue Full definition →		10.28%	6.14%	4.98%	12.02%
Graham Net Nets Full definition →		(0.11)	(0.10)	(0.13)	(0.11)
Graham Number Full definition →		0.11	0.09	0.36	0.35
Earnings Yield Full definition →		(1.18%)	0.05%	1.27%	(1.21%)
Free Cash Flow Yield Full definition →		0.75%	2.22%	4.80%	4.07%
Revenue per Share Full definition →		0.45	0.53	0.49	0.53
Operating CF per Share Full definition →		0.11	0.12	0.06	0.05
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.11	0.12	0.06	0.05
Cash per Share Full definition →		0.56	0.69	0.66	0.70
Shareholders Equity per Share Full definition →		(0.01)	0.09	0.08	(0.06)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(0.01)	0.09	0.08	(0.06)
Free Cash Flow Full definition →		18.36	19.71	9.55	8.05
Working Capital Full definition →		107.82	130.74	133.09	85.19
Capital Expenditures Full definition →		(0.07)	(0.33)	(0.32)	(0.21)
Net Current Asset Value Full definition →		(147.03)	(129.52)	(127.32)	(146.88)
EV/EBIT Full definition →		150.17	55.45	30.93	40.98
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		135.90	50.58	27.55	37.40
Other line items
Average Receivables Full definition →		47.44	45.73	51.31	55.58
Average Payables Full definition →		6.99	2.68	8.91	9.40
Average Inventory Full definition →		56.29	58.42	63.46	74.11
Average Assets Full definition →		345.65	353.29	353.73	373.30
Average Common Equity Full definition →		(14.59)	(7.96)	(11.06)	(14.52)

Show all line items

Columns are period end dates

Stockrow Weekly